231 related articles for article (PubMed ID: 29700093)
1. From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia.
Jakobsen NA; Vyas P
Clin Med (Lond); 2018 Apr; 18(Suppl 2):s47-s53. PubMed ID: 29700093
[TBL] [Abstract][Full Text] [Related]
2. Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Kok CH; Yeung DT; Hiwase DK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396733
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in myeloid malignancies.
Gordon JE; Wong JJ; Rasko JE
Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.
Antić Ž; Lentes J; Bergmann AK
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101511. PubMed ID: 38092485
[TBL] [Abstract][Full Text] [Related]
6. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
Kiyoi H
Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
[TBL] [Abstract][Full Text] [Related]
7. The rocky road to personalized medicine in acute myeloid leukaemia.
Brinda B; Khan I; Parkin B; Konig H
J Cell Mol Med; 2018 Mar; 22(3):1411-1427. PubMed ID: 29327808
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.
Bacher U; Kohlmann A; Haferlach T
Cancer Treat Rev; 2010 Dec; 36(8):637-46. PubMed ID: 20570445
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukaemia.
Short NJ; Rytting ME; Cortes JE
Lancet; 2018 Aug; 392(10147):593-606. PubMed ID: 30078459
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy in haematological malignancies.
Hamilton A; Gallipoli P; Nicholson E; Holyoake TL
J Pathol; 2010 Mar; 220(4):404-18. PubMed ID: 20041451
[TBL] [Abstract][Full Text] [Related]
11. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
Hou HA; Tien HF
J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
[TBL] [Abstract][Full Text] [Related]
13. Application of precision medicine in clinical routine in haematology-Challenges and opportunities.
Wästerlid T; Cavelier L; Haferlach C; Konopleva M; Fröhling S; Östling P; Bullinger L; Fioretos T; Smedby KE
J Intern Med; 2022 Aug; 292(2):243-261. PubMed ID: 35599019
[TBL] [Abstract][Full Text] [Related]
14. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Duncavage EJ; Bagg A; Hasserjian RP; DiNardo CD; Godley LA; Iacobucci I; Jaiswal S; Malcovati L; Vannucchi AM; Patel KP; Arber DA; Arcila ME; Bejar R; Berliner N; Borowitz MJ; Branford S; Brown AL; Cargo CA; Döhner H; Falini B; Garcia-Manero G; Haferlach T; Hellström-Lindberg E; Kim AS; Klco JM; Komrokji R; Lee-Cheun Loh M; Loghavi S; Mullighan CG; Ogawa S; Orazi A; Papaemmanuil E; Reiter A; Ross DM; Savona M; Shimamura A; Skoda RC; Solé F; Stone RM; Tefferi A; Walter MJ; Wu D; Ebert BL; Cazzola M
Blood; 2022 Nov; 140(21):2228-2247. PubMed ID: 36130297
[TBL] [Abstract][Full Text] [Related]
17. Genetics of myeloid malignancies: pathogenetic and clinical implications.
Fröhling S; Scholl C; Gilliland DG; Levine RL
J Clin Oncol; 2005 Sep; 23(26):6285-95. PubMed ID: 16155011
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics and genomics of acute myeloid leukemia.
Snaith O; Poveda-Rogers C; Laczko D; Yang G; Morrissette JJD
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101533. PubMed ID: 38490763
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding and treatment of acute myeloid leukemia.
Watts J; Nimer S
F1000Res; 2018; 7():. PubMed ID: 30135719
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A in haematological malignancies.
Yang L; Rau R; Goodell MA
Nat Rev Cancer; 2015 Mar; 15(3):152-65. PubMed ID: 25693834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
